Optimization of a homogeneous assay for kinase inhibitors in plant extracts

Assay and Drug Development Technologies

Volumn 6, Issue 5, 2008, Pages 673-682

  Dufau, Isabelle ^a   Lazzari, Anne ^a   Samson, Arnaud ^a   Pouny, Isabelle ^a   Ausseil, Frederic ^a,b  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b Parc Technologique du Canal   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; PHOSPHOTRANSFERASE INHIBITOR; PLANT EXTRACT;

ANTIOXIDANT ACTIVITY; ARTICLE; CORRELATION ANALYSIS; DRUG DETERMINATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS;

ADENOSINE TRIPHOSPHATE; ALGORITHMS; BINDING, COMPETITIVE; CALIBRATION; DATA INTERPRETATION, STATISTICAL; DRUG EVALUATION, PRECLINICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; PLANT EXTRACTS; PLANTS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-HCK;

EID: 57049180230     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2008.143     Document Type: Article

References (34)

1. Klumpp M, Boettcher A, Becker D, Meder G, Blank J, Leder K, et al.: Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format. J Biomol Screen 2006;11:617-633.
2. Von Ahsen O, Schmidt A, Klotz M, Parczyk K: Assay concordance between SPA and TR-FRET in high-throughput screening. J Biomol Screen 2006;11:606-616.
3. Sills MA, Weiss D, Pham Q, Schweitzer R, Wu X, Wu JJ: Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening. J Biomol Screen 2002;7:191-213.
4. Bazin H, Préaudat M, Trinquet E, Mathis G: Homogeneous time resolved fluorescence resonance energy transfer using rare earth cryptates as a tool for probing molecular interactions in biology. Spectrochim Acta A 2001;57:2197-2211.
5. Imbert PE, Unterreiner V, Siebert D, Gubler H, Parker C, Gabriel D: Recommendations for the reduction of compound artifacts in time-resolved fluorescence resonance energy transfer assays. Assay Drug Dev Technol 2007;5:363-372.
6. Zou L, Harkey MR, Henderson GL: Effects of intrinsic fluorescence and quenching on fluorescence-based screening of natural products. Phytomedicine 2002;9:263-267.
7. Mishra KP, Ganju L, Sairam M, Banerjee PK, Sawhney RC: A review of high throughput technology for the screening of natural products. Biomed Pharmacother 2008;62:94-98.
8. Kolb JM, Yamanaka G, Manly SP: Use of a novel homogeneous fluorescent technology in high throughput screening. J Biomol Screen 1996;1:203-210.
9. Préaudat M, Ouled-Diaf J, Alpha-Bazin B, Mathis G, Mitsugi T, Aono Y, et al.: A homogeneous caspase-3 activity assay using HTRF technology. J Biomol Screen 2002;7:267-274.
10. McMahon JB, Beutler JA, O'Keefe BR, Goodrum CBB, Myers MA, Boyd MR: Development of a cyanovirin-N-HIV-1 gp120 binding assay for high throughput screening of natural product extracts by time-resolved fluorescence. J Biomol Screen 2000;5:169-176.
11. Ziegler SF, Marth JD, Lewis DB, Perlmutter RM: Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin. Mol Cell Biol 1987;7:2276-2285.
12. Schmidt H, Hoffmann S, Tran T, Stoldt M, Stangler T, Wiesehan K, et al.: Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes. J Mol Biol 2007;365:1517-1532.
13. Ausseil F, Samson A, Aussaguès Y, Vandenberghe I, Créancier L, Pouny I, et al.: High throughput bioluminescence screening of ubiquitin-proteasome pathway inhibitors from chemical and natural sources. J Biomol Screen 2007;12:106-116.
14. Fonrose X, Ausseil F, Soleilhac E, Masson V, David B, Pouny I, et al.: Parthenolide inhibits tubulin carboxypeptidase activity. Cancer Res 2007;67:3371-3378.
15. Reid WV, Laird SA, Meyer CA, Gamez R, Sittenfeld A, Janzen DH, et al.: Biodiversity Prospecting: Using Genetic Resources for Sustainable Development, pp. 303-324. World Resources Institute, Washington, DC, 1993.
16. Zhang JH, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
17. Feder D, Bishop JM: Purification and enzymatic characterization of pp60c-src from human platelets. J Biol Chem 1990;265:8205-8211.
18. Copeland RA: Mechanistic considerations in high-throughput screening. Anal Biochem 2003;320:1-12.
19. Sicilia RJ, Hibbs ML, Bello PA, Bjorge JD, Fujita DJ, Stanley IJ, et al.: Common in vitro substrate specificity and differential Src homology 2 domain accessibility displayed by two members of the Src family of protein-tyrosine kinases, c-Src and Hck. J Biol Chem 1998;273:16756- 16763.
20. Park YW, Cummings RT, Wu L, Zheng S, Cameron PM, Woods A, et al.: Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. Anal Biochem 1999;269:94-104.
21. Ruegg UT, Burgess GM: Staurosporine, K-252 and UCN-01: potent but non-specific inhibitors of protein kinases. Trends Pharmacol Sci 1989;10:218-220.
22. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, et al.: Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem 1996;271:695-701.
23. Lawrence DS, Niu J: Protein kinase inhibitors: the tyrosine-specific protein kinases. Pharmacol Ther 1998;77:81-114.
24. Wu X, Sills MA, Zhang JH: Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability. J Biomol Screen 2005;10:581-589.
25. Wilkinson SE, Parker PJ, Nixon JS: Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 1993;294:335-337.
26. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
27. Lian Z, Zhang C, Li C, Zhou Y: [Studies on chemical constituents of Choerospondias axillaris]. Zhong Yao Cai 2003;26:23-24.
28. Sicheri F, Moarefi I, Kuriyan J: Crystal structure of the Src family tyrosine kinase Hck. Nature 1997;385:602-609.
29. Kabeya LM, de Marchi AA, Kanashiro A, Lopes NP, da Silva CHTP, Pupo MT, et al.: Inhibition of horseradish peroxidase catalytic activity by new 3-phenylcoumarin derivatives: synthesis and structure-activity relationships. Bioorg Med Chem 2007;15:1516-1524.
30. Kashiwada Y, Huang L, Ballas LM, Jiang JB, Janzen WP, Lee KH: New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C. J Med Chem 1994;37:195-200.
31. Rangkadilok N, Sitthimonchai S, Worasuttayangkurn L, Mahidol C, Ruchirawat M, Satayavivad J: Evaluation of free radical scavenging and antityrosinase activities of standardized longan fruit extract. Food Chem Toxicol 2007;45:328-336.
32. Woodward PW, Williams C, Sewing A, Benson N: Improving the design and analysis of high-throughput screening technology comparison experiments using statistical modeling. J Biomol Screen 2006;11:5-12.
33. Hubert CL, Sherling SE, Johnston PA, Stancato LF: Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors. J Biomol Screen 2003;8:399-409.
34. Kashem MA, Nelson RM, Yingling JD, Pullen SS, Prokopowicz AS III, Jones JW, et al.: Three mechanistically distinct kinase assays compared: measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors. J Biomol Screen 2007;12:70-83.